Pf-07820435

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

PF-07820435 is an experimental drug being studied by Pfizer. It is currently in early-phase clinical trials (Phase 1) for various advanced solid tumors, including colorectal cancer. The goal of these early trials is primarily to determine the safest dose and to look for early signs that the drug might be effective. It has been studied both by itself and in combination with another experimental drug called sasanlimab. As of now, PF-07820435 is not approved for treating colorectal cancer or any other condition. The trials involving PF-07820435 in colorectal cancer have been terminated.

Mechanism of Action

PF-07820435 is being investigated as a potential treatment for advanced solid tumors. The specific way it works (its mechanism of action) is still being studied in clinical trials. Researchers are evaluating how it affects tumor cells and the body's response to the tumor.

Side Effects

Because PF-07820435 is still in early-phase clinical trials The full range of potential side effects is not yet known. Safety is a primary focus of these Phase 1 studies. Information about specific side effects experienced by patients in the trials is typically collected and analyzed by the researchers But detailed public reports are often limited for terminated trials or early-phase studies. Patients participating in clinical trials are closely monitored for any adverse events.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT06285097 Phase 1
Terminated
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
United States, Japan, Puerto Rico

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
787 trials
Leucovorin
Other Medications
648 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.